T. Rowe Price Investment Management’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77M | Buy |
8,275,257
+720,663
| +10% | +$6.7M | 0.05% | 324 |
|
|
2025
Q1 | $50.8M | Buy |
7,554,594
+2,054,640
| +37% | +$13.8M | 0.03% | 389 |
|
|
2024
Q4 | $58.4M | Sell |
5,499,954
-262,059
| -5% | -$2.78M | 0.04% | 385 |
|
|
2024
Q3 | $84.2M | Buy |
5,762,013
+1,883,418
| +49% | +$27.5M | 0.05% | 327 |
|
|
2024
Q2 | $46.9M | Buy |
3,878,595
+2,362,141
| +156% | +$28.6M | 0.03% | 395 |
|
|
2024
Q1 | $37.4M | Buy |
+1,516,454
| New | +$37.4M | 0.02% | 440 |
|